Personalis

Yahoo Finance • 28 days ago

Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing

FREMONT, Calif., September 03, 2025--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca phase 3 clinical trial in lung cancer (NeoADAURA). The find... Full story

Yahoo Finance • last month

Personalis gains as VA awards work order worth up to $13.5M

[America / United States Department of Veterans Affairs.] Kiyoshi Tanno Shares of Personalis (NASDAQ:PSNL [https://seekingalpha.com/symbol/PSNL]) added ~5% in the premarket on Friday after the cancer test maker announced that it received... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK ETFs make major buys in Deere & Co, Exact Sciences stock

Cathie Wood’s ARK ETF published their daily trades for Thursday, 14th August 2025, revealing a series of significant stock purchases across various sectors. Topping the list in dollar value was the acquisition of 64,789 shares of DEERE & C... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK makes major moves in Trade Desk and Block stock

Cathie Wood’s ARK ETFs have once again made significant trades on Tuesday, 12 August 2025, with a major focus on tech and biotech stocks. The most substantial trade of the day was the purchase of 738,367 shares of Trade Desk Inc (NASDAQ:... Full story

Yahoo Finance • 2 months ago

Personalis outlines $70M–$80M revenue target for 2025 amid 59% sequential clinical test growth and revised biopharma outlook

Earnings Call Insights: Personalis, Inc. (PSNL) Q2 2025 MANAGEMENT VIEW * Christopher M. Hall, CEO, stated the quarter was marked by "outstanding execution of our win in MRD strategy," highlighting that "clinical adoption of NeXT Perso... Full story

Yahoo Finance • 3 months ago

Tempus AI, Inc. (TEM) and Personalis Join Forces to Take on Colorectal Cancer

Given the company’s popularity among hedge funds and the bullish sentiment surrounding it, Tempus AI, Inc. (NASDAQ:TEM) makes it to our list of the Top 10 AI Infrastructure Stocks to Buy Now.Tempus AI, Inc. (TEM) and Personalis Join Forces... Full story

Yahoo Finance • 3 months ago

Personalis extends Tempus agreement to add colorectal cancer indication

Personalis, Inc. (NASDAQ:PSNL), a medical laboratory services company with a market capitalization of $625 million and impressive revenue growth of 15.6% over the last twelve months, announced Tuesday that it has amended its existing comme... Full story

Yahoo Finance • 2 years ago

Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers

SALT LAKE CITY and FREMONT, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq: MYGN), a leader in genetic testing and precision medicine, and Personalis, Inc., a leader in advanced genomics for precision oncology, (... Full story

Yahoo Finance • 2 years ago

Personalis Files Second Patent Infringement Suit Against Foresight Diagnostics

Infringed patents part of industry-leading intellectual property position in whole genome, tumor-informed minimal residual disease testing FREMONT, Calif., June 26, 2023--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL) today announced th... Full story

Yahoo Finance • 2 years ago

Dr. Kenneth J. Widder Joins Personalis Board of Directors

FREMONT, Calif., June 13, 2023--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL) today announced that it has appointed Kenneth J. Widder, M.D., to its Board of Directors. Dr. Widder currently serves on the boards of QuidelOrtho Corporatio... Full story

Yahoo Finance • 2 years ago

Q1 2023 Personalis Inc Earnings Call

Participants Aaron L. Tachibana; CFO & COO; Personalis, Inc. Caroline V. Corner; MD; Westwicke Partners, LLC Christopher M. Hall; President, CEO & Director; Personalis, Inc. Richard Chen; Executive VP of R&D and Chief Medical Officer;... Full story

Yahoo Finance • 2 years ago

Personalis to Announce First Quarter 2023 Financial Results

FREMONT, Calif., April 19, 2023--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its first quarter 2023 financial results on Wednesday, May 3, 202... Full story

Yahoo Finance • 3 years ago

Q4 2022 Personalis Inc Earnings Call

Participants Aaron L. Tachibana; Interim CEO & CFO; Personalis, Inc. Chris Hall Richard Chen; Senior VP of R&D and Chief Medical Officer; Personalis, Inc. Unidentified Analyst Vivien Bias Caroline V. Corner; MD; Westwicke Partners, L... Full story

Yahoo Finance • 3 years ago

Personalis Reports Preliminary Fourth Quarter and Full Year 2022 Revenue

FREMONT, Calif., January 04, 2023--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported unaudited preliminary revenue for the fourth quarter and full year ended December 31,... Full story

Yahoo Finance • 3 years ago

Personalis Announces Expansion of Its Patent Portfolio Related to Tumor-Informed Detection of Molecular Residual Disease

MENLO PARK, Calif., July 12, 2022--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, has added another patent family to its molecular residual disease (MRD)-related IP portfolio, with priority to J... Full story

Yahoo Finance • 3 years ago

Strong week for Personalis (NASDAQ:PSNL) shareholders doesn't alleviate pain of one-year loss

It's nice to see the Personalis, Inc. (NASDAQ:PSNL) share price up 20% in a week. But that is meagre solace when you consider how the price has plummeted over the last year. During that time the share price has plummeted like a stone, down... Full story

Yahoo Finance • 3 years ago

Personalis to Announce First Quarter 2022 Financial Results

MENLO PARK, Calif., April 20, 2022--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it will release its first quarter 2022 financial results on Wednesday, May 4, 2022. In con... Full story

Yahoo Finance • 3 years ago

Cathie Wood’s Portfolio: 10 Stocks Under $10

In this article, we discuss 10 stocks under $10 in Cathie Wood’s portfolio. If you want to see some more stocks in this selection, go see Cathie Wood's Portfolio: 5 Stocks Under $10. Cathie Wood is the chief executive officer and chief in... Full story

Yahoo Finance • 4 years ago

Personalis to Present at the 21st Annual Needham Virtual Healthcare Conference

MENLO PARK, Calif., March 31, 2022--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the 21st Annual Needham Virtual Healthcare Conference... Full story